Subject: Re: Moderna - MRNA
it's rare for new platforms to get a 'free' look at full spectrum clinical data on a global scale via gov help.

that experience is the embedded option in the ~2 mRNA giant rivals.

think of another promising platform, e.g., crispr, and consider the odds\cost against such a knowledge windfall.